-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Neutral on Conmed, Lowers Price Target to $40

Benzinga·05/18/2026 17:41:46
Listen to the news
B of A Securities analyst Travis Steed maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $52 to $40.